References

  1. Ben Maïz Hédi. Nephrology in Tunisia: From yesterday to now. Nephrol ther. 2010;6(3):173-8. PubMed | Google Scholar

  2. Frimat Luc, Loos-Ayav Carole, Briançon Serge, Kessler Michèle. Epidémiologie des maladies rénales chroniques. EMC-Néphrologie. 2005;139-157. Google Scholar

  3. Gariani Karim, De Seigneux Sophie, Pechère-Bertschi Antoinette, Philippe Jacques, Martin Pierre-Yves. Diabetic nephropathy: an update. Rev Med Suisse. 2012 Feb 29;8(330):473-9.

  4. Niaudet Patrick. Signes cliniques et biologiques des néphropathies glomérulaires. EMC-Pédiatrie. 2005;12-30.

  5. López-Novoa José M, Rodríguez-Peña Ana B, Ortiz Alberto, Martínez-Salgado Carlos, López Hernández Francisco J. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Transl Med. 2011 Jan 20;9:13. Google Scholar

  6. Kramer Anneke, Pippias Maria, Stel Vianda S, Bonthuis Marjolein, Abad Diez José Maria, Afentakis Nikolaos et al. Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus. Clin Kidney J. 2016 Jun;9(3):457-69. PubMed | Google Scholar

  7. Kramer Anneke, Stel Vianda, Zoccali Carmine, Heaf James, Ansell David, Grönhagen-Riska Carola et al. ERA-EDTA Registry, an update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. Nephrol Dial Transplant. 2009 Dec;24(12):3557-66. PubMed | Google Scholar

  8. Kessler Michèle, Ayav Carole, Erpelding Marie-Line, Couchoud Cécile. Trends in the characteristics of ESRD patients at the initiation of dialysis. Nephrol Ther. 2012 Dec;8(7):521-6. PubMed | Google Scholar

  9. Pippias Maria, Stel Vianda S, Abad Diez José Maria, Afentakis Nikolaos, Herrero-Calvo Jose Antonio, Arias Manuel et al. Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report. Clin Kidney J. 2015 Jun;8(3):248-61. PubMed | Google Scholar

  10. Iseki Kunitoshi. Predictors of diabetic end-stage renal disease in Japan. Nephrology (Carlton). 2005 Oct;10 Suppl:S2-6. PubMed | Google Scholar

  11. Collins Allan J, Foley Robert N, Herzog Charles, Chavers Blanche, Gilbertson David, Herzog Charles et al. US Renal Data System 2012 Annual Data Report. Am J Kidney Dis. 2013 Jan;61(1 Suppl 1):A7, e1-476. PubMed | Google Scholar

  12. Burrows Nilka Rios, Li Yanfeng, Geiss Linda S. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Diabetes Care. 2010 Jan;33(1):73-7. PubMed | Google Scholar

  13. Tamayo Teresa, Rosenbauer Joachim, Wild Sarah, Spijkerman Annemieke MW, Baan Caroline, Forouhi Nita Gandhi et al. Diabetes in Europe: an update. Diabetes Res Clin Pract. 2014 Feb;103(2):206-17. In Press.

  14. Preston Richard A, Epstein Murray. Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. J Hypertens. 1997 Dec;15(12 Pt 1):1365-77. Google Scholar

  15. Valderrábano Fernando, Gómez-Campderá Francisco, Jones Elizabeth HP. Hypertension as cause of end-stage renal disease: lessons from international registries. Kidney Int Suppl. 1998 Dec;68:S60-6. Google Scholar

  16. Hamouda Chokri, Ben Hamida Mylène, Benzarti Najla, Zouari Béchir. Tunisian survey about organ donation, attitude and opinion? Presse Med. 2010 Jan;39(1):e11-6. Google Scholar

  17. Witczak Bartlomiej J, Leivestad Torbjorn, Line Pal Dag, Holdaas Hallvard, Reisaeter Anna V, Jenssen Trond G et al. Experience from an active preemptive kidney transplantation program (809 cases ) revisited. Transplantation. 2009 Sep 15;88(5):672-7. PubMed | Google Scholar